Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page
- Check5 days agoChange DetectedThe website has updated its contact information for various principal investigators and staff, removing the 'Principal Investigator' designation from the names while retaining their contact details, and has also revised the version from v2.13.3 to v2.14.0.SummaryDifference12%
- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check41 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference2%
- Check56 days agoChange DetectedSeveral key resources related to genetics and clinical trials have been removed, including links to MedlinePlus and DailyMed, which may impact access to important health information.SummaryDifference3%
- Check63 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added including links to MedlinePlus and DailyMed, as well as additional data fields for study information.SummaryDifference3%
- Check78 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.